APH1B and Hypertension: Functional consequences of reduced gene dosage of Aph1b were also observed in the APO-SUS/-UNSUS rat model [9], an animal model with complex features, including an impaired vasorelaxation response to adrenergic stimuli [6], [7], which increases the risk for the development of hypertension and vascular diseases.